These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19813016)

  • 1. [Albumin eye drops for treatment of ocular surface diseases].
    Unterlauft JD; Kohlhaas M; Hofbauer I; Kasper K; Geerling G
    Ophthalmologe; 2009 Oct; 106(10):932-7. PubMed ID: 19813016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autologous serum and alternative blood products for the treatment of ocular surface disorders].
    Geerling G; Unterlauft JD; Kasper K; Schrader S; Opitz A; Hartwig D
    Ophthalmologe; 2008 Jul; 105(7):623-31. PubMed ID: 18607606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
    Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
    Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects.
    Mondy P; Brama T; Fisher J; Gemelli CN; Chee K; Keegan A; Waller D
    Transfus Apher Sci; 2015 Dec; 53(3):404-11. PubMed ID: 26626963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous serum eye drops for the treatment of ocular surface disease.
    Azari AA; Rapuano CJ
    Eye Contact Lens; 2015 May; 41(3):133-40. PubMed ID: 25603439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous serum for ocular surface diseases.
    Quinto GG; Campos M; Behrens A
    Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin rescues ocular epithelial cells from cell death in dry eye.
    Higuchi A; Ueno R; Shimmura S; Suematsu M; Dogru M; Tsubota K
    Curr Eye Res; 2007 Feb; 32(2):83-8. PubMed ID: 17364740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous serum eye drops for the treatment of dry eye diseases.
    Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K
    Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Serum and Serum Components.
    Higuchi A
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES121-DES129. PubMed ID: 30481816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous serum eye drops for ocular surface disorders.
    Cui D; Li G; Akpek EK
    Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):493-499. PubMed ID: 34261888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology.
    Shtein RM; Shen JF; Kuo AN; Hammersmith KM; Li JY; Weikert MP
    Ophthalmology; 2020 Jan; 127(1):128-133. PubMed ID: 31561880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface.
    Semeraro F; Forbice E; Nascimbeni G; Taglietti M; Romano V; Guerra G; Costagliola C
    In Vivo; 2016 11-12; 30(6):931-938. PubMed ID: 27815483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous serum eye drops for ocular surface disorders.
    Geerling G; Maclennan S; Hartwig D
    Br J Ophthalmol; 2004 Nov; 88(11):1467-74. PubMed ID: 15489495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of corneal erosions and 'dry eye' with Solcoseryl and Vitasic eye drops.
    Krannig HM; Rohde-Germann H; Straub W
    Ophthalmologica; 1989; 199(2-3):100-5. PubMed ID: 2587017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous serum eye drops for the treatment of persistent corneal epithelial defects.
    Arain MA; Dar AJ; Adeeb L
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):737-9. PubMed ID: 24112261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of autologous serum eye drops with different diluents.
    Cho YK; Huang W; Kim GY; Lim BS
    Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].
    Kasper K; Godenschweger L; Hartwig D; Unterlauft JD; Seitz B; Geerling G
    Ophthalmologe; 2008 Jul; 105(7):644-9. PubMed ID: 18612645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.